Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation

Blood

Volumn 112, Issue 8, 2008, Pages 3484-3487

  Woolfrey, Ann E ^a,b   Malhotra, Uma ^a,c   Harrington, Robert D ^b   McNevin, John ^a,b   Manley, Thomas J ^a,b   Riddell, Stanley R ^a,b   Coombs, Robert W ^b   Appelbaum, Frederick R ^a,b   Corey, Larry ^a,b   Storb, Rainer ^a,b  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AZATHIOPRINE; BECLOMETASONE; BUDESONIDE; CYCLOSPORIN; EFAVIRENZ; EPITOPE; FLUDARABINE; FOSCARNET; GRANULOCYTE COLONY STIMULATING FACTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEVIRAPINE; PREDNISONE; TACROLIMUS; TENOFOVIR; VIRUS RNA; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; FEASIBILITY STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LIVER TOXICITY; LYMPHOCYTE COUNT; MALE; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; ORGAN DONOR; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION; WHOLE BODY RADIATION; ACUTE GRANULOCYTIC LEUKEMIA; ALLOTRANSPLANTATION; CHEMISTRY; CLINICAL TRIAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNE SYSTEM; METABOLISM; VIROLOGY;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD8-POSITIVE T-LYMPHOCYTES; CYCLOSPORINE; EPITOPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOID, ACUTE; MALE; MYCOPHENOLIC ACID; TRANSPLANTATION, HOMOLOGOUS;

EID: 54049098828     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-05-157511     Document Type: Article

References (20)

1. Krishnan A, Molina A, Zaia J, et al. Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood. 2005;105:874-878.
2. Maris MB, Niederwieser D, Sandmaier BM, et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood. 2003;102:2021-2030.
3. Maris MB, Sandmaier BM, Storer BE, et al. Unrelated donor granulocyte colony-stimulating factormobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing. Biol Blood Marrow Transplant. 2006;12:454-465.
4. Zuckerman RA, Lucchetti A, Whittington WL, et al. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis. 2007;196:1500-1508.
5. Jackson JB, Drew J, Lin HJ, et al. Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group. J Clin Microbiol. 1993;31:3123-3128.
6. Jackson JB, Coombs RW, Sannerud K, Rhame FS, Balfour HH Jr. Rapid and sensitive viral culture method for human immunodeficiency virus type 1. J Clin Microbiol. 1988;26:1416-1418.
7. Bihl F, Narayan M, Chisholm JV III, etal. Lytic and latent antigens of the human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus induce T-cell responses with similar functional properties and memory phenotypes. J Virol. 2007;81:4904-4908.
8. Larsson M, Jin X, Ramratnam B, et al. Arecombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS. 1999;13:767-777.
9. Quillent C, Oberlin E, Braun J, et al. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet. 1998;351:14-18.
10. Baylor MS, Johann-Liang R. Hepatotoxicity associated with nevirapine use (Review). J Acquir Immune Defic Syndr. 2004;35:538-539.
11. Phillips E, Mallal S. Drug hypersensitivity in HIV [review]. Curr Opin Allergy Clin Immunol. 2007;7: 324-330.
12. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med. 1996;2: 1240-1243.
13. Bowden RA, Coombs RW, Nikora BH, et al. Progression of human immunodeficiency virus type-1 infection after allogeneic marrow transplantation. Am J Med. 1990;88:49N-52N.
14. Aboulafia DM, Mitsuyasu RT, Miles SA. Syngeneic bone-marrow transplantation and failure to eradicate HIV. AIDS. 1991;5:344.
15. Gabarre J, Leblond V, Sutton L, et al. Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma. Bone Marrow Transplant. 1996;18:1195-1197.
16. Davis KG, Hayward A, Ozturk G, Kohler PF. Lymphocyte transfusion in case of acquired immunodeficiency syndrome. Lancet. 1983;1:599-600.
17. Lane HC, Zunich KM, Wilson W, et al. Syngeneic bone marrow transplantation and adoptive transfer of peripheral blood lymphocytes combined with zidovudine in human immunodeficiency virus (HIV) infection. Ann Intern Med. 1990;113:512-519.
18. Vilmer E, Rhodes-Feuillette A, Rabian C, et al. Clinical and immunological restoration in patients with AIDS after marrow transplantation, using lymphocyte transfusions from the marrow donor. Transplantation. 1987;44:25-29.
19. Verdonck LF, de Gast GC, Lange JM, Schuurman HJ, Dekker AW, Bast BJ. Syngeneic leukocytes together with suramin failed to improve immunodeficiency in a case of transfusion-associated AIDS after syngeneic bone marrow transplantation. Blood. 1988;71:666-671.
20. Kang EM, De Witte M, Malech H, et al. Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome. Blood. 2002;99: 698-701.